1h Free Analyst Time
The epigenetics market is forecasted to grow by USD 1.47 billion during 2023-2028, accelerating at a CAGR of 14.75% during the forecast period. The report on the epigenetics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising epigenetic applications in non-oncology diseases, increasing prevalence of CVDs, and rising strategic collaboration among vendors.
The epigenetics market is segmented as below:
By Application
- Oncology
- Non-oncology
By Product
- Reagents
- Kits
- Enzymes and others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the epigenetics market covers the following areas:
- Epigenetics market sizing
- Epigenetics market forecast
- Epigenetics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global epigenetics market: Abcam plc, Active Motif Inc., Agilent Technologies Inc., Bio Rad Laboratories Inc., Bio Techne Corp., Eisai Co. Ltd., Element Biosciences Inc, EpiGentek Group Inc., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Illumina Inc., Merck KGaA, New England Biolabs Inc., Novartis AG, Pacific Biosciences of California Inc., PerkinElmer Inc, Promega Corp., QIAGEN NV, Thermo Fisher Scientific Inc., Zymo Research Corp., and CellCentric Ltd..Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is technological advances in life sciences industry.'
According to the report, one of the major drivers for this market is the rising epigenetic applications in non-oncology diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abcam plc
- Active Motif Inc.
- Agilent Technologies Inc.
- Bio Rad Laboratories Inc.
- Bio Techne Corp.
- Eisai Co. Ltd.
- Element Biosciences Inc
- EpiGentek Group Inc.
- Eurofins Scientific SE
- F. Hoffmann La Roche Ltd.
- Illumina Inc.
- Merck KGaA
- New England Biolabs Inc.
- Novartis AG
- Pacific Biosciences of California Inc.
- PerkinElmer Inc
- Promega Corp.
- QIAGEN NV
- Thermo Fisher Scientific Inc.
- Zymo Research Corp.
- CellCentric Ltd.
